Trevi Therapeutics TRVI
NASDAQ TRVI
$13.82 -0.36 (-2.54%)
As of: Oct 2, 2026 · 3:11 PM EDT

Trevi Therapeutics (TRVI) Shares Outstanding (Diluted) (2021 - 2026)

Updated

Trevi Therapeutics (TRVI) posted Shares Outstanding (Diluted) of 156.6 million for Q2 2026, up 20.1% from 130.35 million a year earlier and up 7.6% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

For FY2025, Trevi Therapeutics' Shares Outstanding (Diluted) came in at 134.75 million, up 32.1% from FY2024.

  • Annual Shares Outstanding (Diluted) has increased for four consecutive years, with a four-year compound annual growth rate of 55.8% (FY2021 to FY2025).
  • In prior years, Trevi Therapeutics' Shares Outstanding (Diluted) was 101.97 million in FY2024 (+3.0%), 99.03 million in FY2023 (+53.4%), 64.54 million in FY2022 (+182.6%) and 22.84 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last 17 quarters, with growth averaging 21.4% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.9% in Q1 2024 to 220.1% in Q1 2023.
  • According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 145.59 million (Q1 2026), 134.75 million (Q4 2025) and 145.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Trevi Therapeutics 2.04 Bn 2.04 Bn - 156.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.60 Mn
Mar 31, 2026 145.59 Mn
Dec 31, 2025 134.75 Mn
Sep 30, 2025 145.10 Mn
Jun 30, 2025 130.35 Mn
Mar 31, 2025 117.61 Mn
Dec 31, 2024 101.97 Mn
Sep 30, 2024 101.28 Mn
Jun 30, 2024 101.04 Mn
Mar 31, 2024 99.52 Mn
Dec 31, 2023 99.03 Mn
Sep 30, 2023 99.33 Mn
Jun 30, 2023 98.70 Mn
Mar 31, 2023 98.61 Mn
Dec 31, 2022 64.54 Mn
Sep 30, 2022 68.90 Mn
Jun 30, 2022 59.54 Mn
Mar 31, 2022 30.81 Mn
Dec 31, 2021 22.84 Mn
Sep 30, 2021 21.61 Mn
API Access

Trevi Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TRVI&period=max&api_key=YOUR_API_KEY